EUVIMEDEUVIMED entdecken
Crossref

Comprehensive Evaluation of Recurrence-Free Survival in Luminal pT1 Breast Cancer with Nodal Involvement: A Real-World Analysis

Thamilyn Yoshizaki Saruwatari, Vladmir Claudio Cordeiro Lima

Brazilian Journal of Oncology · 26.06.2026 · 22 (CP)

DOI: 10.1055/s-0046-1825246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brazilian Journal of Oncology, erschienen am 26.06.2026. Verfasst von Thamilyn Yoshizaki Saruwatari und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

All articles of this category (opens in new window) Address for correspondence Vladmir Claudio Cordeiro Lima (vladmir.lima@accamargo.org.br)

Objective

Breast cancer encompasses a spectrum of molecular subtypes, among which the luminal subtype predominates as the most frequently diagnosed. The likelihood of lymph node involvement diminishes with earlier T staging, particularly in tumors classified as pT1. In cases of pT1 breast cancer with positive lymph nodes (pT1pN+), extended follow-up is imperative to accurately assess recurrence rates and the long-term efficacy of therapeutic interventions, given the median progression-free survival (PFS) ranging from 6 to 9 years for these neoplasms .

Methods

This is an observational, analytical, retrospective cohort study with comprehensive data collection from patients treated at a specialized oncology center from 2008 onward. Eligible patients had localized luminal B breast cancer with pathological staging pT1 and clinically or sentinel node-positive lymph nodes .

Results

A cohort of 272 patients with luminal pT1pN+ breast cancer was analyzed, with a median follow-up duration of 74.2 months (approximately 6.2 years; range: 12–204 months). The distribution across T1 substages was as follows: 6.3% T1a, 19% T1b, and 74% T1c. Recurrence was observed in 33 patients, with rates of 13% in T1c, 7.6% in T1b, and 11% in T1a. Among those with recurrence, prior exposure to adjuvant chemotherapy was noted in 50% of pT1a, 75% of pT1b, and 100% of pT1c cases. The median PFS for the pT1c subgroup was 170 months (95% confidence interval [CI]: 150–not reached), whereas the median RFS was not reached for pT1a and pT1b subgroups. Cox proportional hazards regression analysis revealed no statistically significant difference in recurrence risk between pT1b (hazard ratio [HR]=0.85, 95% CI: 0.32–2.22, p=0.738) or pT1a (HR=0.61, 95% CI: 0.14–2.70, p=0.512) compared to pT1c. Notably, lymphovascular invasion (LVI) emerged as a significant predictor of recurrence (HR=2.10, 95% CI: 1.02–4.33, p=0.044), underscoring its prognostic relevance .

Conclusion

Patients with luminal T1c breast cancer with nodal involvement exhibit a higher risk of recurrence within the T1 staging, consistent with existing literature. Further data are needed on the characteristics of T1a and T1b tumors with positive lymph nodes, as limited information is available for this population. Publication History Article published online: 26 June 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil Bibliographical Record Thamilyn Yoshizaki Saruwatari, Vladmir Claudio Cordeiro Lima. Comprehensive Evaluation of Recurrence-Free Survival in Luminal pT1 Breast Cancer with Nodal Involvement: A Real-World Analysis. Brazilian Journal of Oncology 2026; 22. DOI: 10.1055/s-0046-1825246

Zitieren

APA

Saruwatari, T. Y., & Lima, V. C. C. (2026). Comprehensive Evaluation of Recurrence-Free Survival in Luminal pT1 Breast Cancer with Nodal Involvement: A Real-World Analysis. Brazilian Journal of Oncology, 22(CP). https://doi.org/10.1055/s-0046-1825246

Vancouver

Saruwatari TY, Lima VCC. Comprehensive Evaluation of Recurrence-Free Survival in Luminal pT1 Breast Cancer with Nodal Involvement: A Real-World Analysis. Brazilian Journal of Oncology. 2026;22(CP). doi:10.1055/s-0046-1825246

BibTeX
@article{Saruwatari2026,
  author = {Saruwatari, Thamilyn Yoshizaki and Lima, Vladmir Claudio Cordeiro},
  title = {Comprehensive Evaluation of Recurrence-Free Survival in Luminal pT1 Breast Cancer with Nodal Involvement: A Real-World Analysis},
  journal = {Brazilian Journal of Oncology},
  year = {2026},
  volume = {22},
  number = {CP},
  doi = {10.1055/s-0046-1825246}
}
Kostenlos starten →